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Lead and mercury are widespread environmental pollutants. Workers in the 
mining industry and in the manufacture of storage batteries, sheet-lead, paint, 
pipes, and ceramics are exposed to inorganic lead salts; gasoline is also a major 
source of environmental lead (1, 2). Acute and chronic lead poisoning from paint 
in impoverished urban areas is a major pediatric problem (3). Organic mercury 
salts have been employed for many years as fungicides in agriculture and in the 
paper industry (4). As a result of industrial pollution of water, it has been shown 
that fish accumulate mercury in the form of methyl mercury (4). In man, one of 
the most dangerous features of lead and methyl mercury poisoning is the insid- 
iousness of its  development. Absorption,  excretion, and  storage of  excessive 
quantities of these heavy metals may occur without overt clinical manifestations 
of intoxication (1). 
The ability to synthesize heme is a biochemical function which is common to 
all  aerobic cells.  A  substantial  fraction of the heine synthesized in  the liver 
serves as a prosthetic group for the microsomal hemoprotein, cytochrome P-450. 
This hemoprotein plays a  central role in the hepatic detoxification of drugs, 
hormones, and foreign chemicals. The ability of heavy metals, such as lead, to 
impair heine synthesis in erythroid cells through inhibition of several sulfhydryl 
enzymes is well known, as are the hematological consequences of this action 
(5, 6).  The possibility that lead and other metals may similarly impair heine 
synthesis or the function of hemoproteins, such  as cytochrome P-450, in  the 
liver has however not been studied.  In the experiments described below, the 
acute effects of lead chloride and methyl mercuric chloride on cytochrome P-450 
and model drug metabolizing enzyme reactions coupled to the mixed function 
oxidase, such as the N-demethylation of ethylmorphine and the hydroxylation 
of aniline were examined. The acute effects of lead and methyl mercury on the 
duration of action of hexobarbital in the intact rat were also determined. 
Male  Sprague-Dawley rats each weighing 120-150  g  were used.  Lead  chloride  (PbC12), 
dissolved in 0.9%  NaCI solution, was administered intravenously at  a  dosage of 5  mg/kg. 
Methyl  mercuric  chloride  (CH3HgC1),  dissolved  in  corn  oil,  was  administered  intraperi- 
toneally at a  dosage of 5 mg/kg. Control rats received the vehicle only. Animals were sacri- 
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riced 24 hr after administration  of these compounds. Livers were removed and microsomes 
were prepared as described previously (7). Microsomes  were suspended in 1.15% KC1 solution 
such that each milliliter contained the equivalent of 250 mg of liver, wet weight. The compo- 
sition  of  the  incubation  mixture  for  the  determination  of  ethylmorphine  N-demethylase 
activity has been described previously (7). Formaldehyde formed from the N-demethylation 
reaction was measured by the method of Nash (8) as modified by Anders and Mannering (9). 
Aniline hydroxylase activity was measured as described previously (10). Cytochrome P-450 
contents were assayed by the method of Omura and Sato  (ll) from the carbon monoxide 
difference spectrum of dithionite-reduced microsnmes using an extinction  coefficient of 91 
m~  -1 cm  -1 between 450 and 490 m#. To determine the hexobarbital sleeping time, sodium 
hexobarbital was administered intraperitoneally at a dosage of 100 mg/kg and the duration 
of loss of the righting reflex was determined. Protein contents were determined by the method 
of Sutherland et al. (12) using bovine serum albumin  as a standard. 
Ethylmorphine and aniline were chosen as substrates in these studies because 
they are representative of type I  and type II substrates (13,  14). Type I  sub- 
TABLE  I 
E~ects  of Lead  and  Methyl  Mercuric  Chlorides  on  Cytochrome  P-450  Contents,  Microsomal 
Oxidations of Ethylmorphine and Aniline, and Hexobarbital  Sleeping Time in Rats 
Ethylmorphine  Aniline hydroxylation 
N-demethy]ation ~.moles m~moles p aminophenol  Cytochrome P-450  Itexobarbital  sleeping time  Treatment  IICHO formed/mg  formed/mg protein  m~moles/mg protein  (rain) 
protein per hr  per hr 
Control  0.312  4-  0.034  41.79  4-  2.78  0.506  4-  0.053  57  4-  15 
PbCle  0.151  4-  0.026*  25.66  4-  1.88"  0.331  4-  0.017"  106  4-  6* 
Control  0.329  4-  0.048  45.54  -4-  2.28  0.535  4-  0.014  40  4-  7 
CH3HgCI  0.182  4-  0.033*  25.90  4-  5.61"  0.321  4-  0.042*  65  4-  6* 
Each value represents mean 4- sE of rive rats. 
* Values significantly,  different from the respective control values (P <  0.05). 
strates interact with the microsomal hemoprotein, cytochrome P-450,  to give a 
difference spectrum with a Xmax in the range of 385-390 m~ and a  Xmin in the 
range of 418-427 m~; the Xmax and Xmln given by type II compounds are  425- 
435 and 390-405 m~, respectively (13). Mter administration of 5  mg/kg PbC12, 
intravenously,  or 5 mg/kg CH~HgC1, intraperitoneally, to rats,  ethylmorphine 
N-demethylase and aniline hydroxylase activities of hepatic  microsomes were 
decreased by 40-50 % of control values in 24 hr  (Table I).  Concomitant with 
a decrease in the microsomal oxidations of ethylmorphine and aniline, there was 
a  marked decrease in cytochrome P-450 content of liver microsomes obtained 
from rats administered lead or methyl mercury (Table I).  Decreases  in cyto- 
chrome P-450 contents and N-demethylase and hydroxylase activities were also 
observable when the dosages of PbCl~ and CH3HgC1 were decreased to 2.5 mg/ 
kg.  Hexobarbital has  been widely used as a substrate for investigation of the 
activity of liver microsomal enzymes and hexobarbital-induced sleeping time 
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Table I, administration of lead or methyl mercury to rats resulted in a signifi- 
cant prolongation of hexobarbital-induced sleeping time. Thus the in vitro in- 
hibition of microsomal oxidations is accompanied by enhanced pharmacological 
action of hexobarbital. 
The mechanism of action of lead and methyl mercury on the hepatic mixed 
function oxidase system in these studies may be comparable with that of the 
former metal on erythroid precursors in the bone marrow. Several heme path- 
way  enzymes,  such  as  ~-aminolevulinic  acid  dehydratase,  porphobilinogen 
deaminase,  uroporphyrinogen  decarboxylase,  and  heme  synthetase  possess 
essential sulfhydryl groups and lead and methyl mercury may exert their effects 
by inhibiting one or more of these enzymes, resulting in inhibition of the forma- 
tion of cytochrome P-450. The short half-life of cytochrome P-450 in the liver 
(15) would permit such a mode of action. These heavy metals may however also 
exert a direct action on the hepatic mixed function oxidase since there is a sug- 
gestion of involvement of sulfhydryl groups in the integrity and electron-trans- 
fer  function  of  cytochrome  P-450  (16)  as  well  as  nicotinamide  adenine 
dinucleotide phosphate-cytochrome c  reductase  activities (17), both of which 
are components of the microsomal drug metabolizing enzyme system. 
It is not known whether the effects of acute exposure to these metals on the 
cytochrome P-450 system in experimental animals are comparable with those 
produced by acute intoxication with lead in children, for example; this question 
is now being investigated in clinical studies. The doses of lead employed in these 
experiments are however within the range of total body burden of this metal 
found previously lead-poisoned individuals  (2). 
SUMMARY 
The rat liver mixed function oxidase system which is responsible for the me- 
tabolism  of  endogenous  and  exogenous  compounds  has  been  shown  to  be 
affected by lead and methyl mercury. Administration of these environmental 
pollutants to rats results in a decrease in cytochrome P-450 content and inhibi- 
tion of in vitro N-demethylase and hydroxylase activities. The in vitro enzyme- 
inhibiting effects of the metals found pharmacological expression in the whole 
animal by prolongation of hexobarbital-induced sleeping times. 
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